It's a multi-patented ingredient from La Roche-Posay that's available in La Roche Posay's Mela B3 franchise, including its MelaB3 serum and MelaB3 SPF30. L'Oréal Paris and Vichy will also follow in La Roche Posay's footsteps with future product launches that contain Melasyl.
Melasyl is designed to address pigmentation disorders that lead to age spots and post-acne marks, such as sunspots, vitiligo, and hyperpigmentation disorders. Melasyl is pronounced "MEH-luh-sil".
Melasyl was first presented at the World Congress of Dermatology 2023 in Singapore, alongside the first worldwide epidemiological study on pigmentary disorders. It has been featured at the American Academy of Dermatology's annual meeting in San Diego from March 8-12, 2024.
